Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Psoriasis Patients with Unsatisfactory Response to Etanercept
NCT00927069Phase 3Completed
- Sponsor
- Innovaderm Research
- Start
- Mar 2007
- Primary completion
- Sep 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Innovaderm Research. Started Mar 2007; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00927069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927069.